Martin Nicklasson - Chief Executive Officer Born 1955. Holds a degree in Pharmacy and a Ph.D. in Pharmaceutical Science. Associate professor at the Faculty of Pharmacy, Uppsala University, since 1985. Former member of the executive management at AstraZeneca Plc. Has previously held a number of leadership positions within Astra and AstraZeneca, including CEO of Astra Pain Control AB, CEO of Astra Hässle AB, head of Gastrointestinal Franchise, Executive Vice President of Global Drug development, Executive Vice President of Global Marketing and CEO of AstraZeneca AB.  Martin has also held research leadership positions at Kabi Pharmacia.
		Göran Arvidson – Vice President, Chief Financial Officer and Head of Finance Born 1960. B.Sc. in Economics and Business Administration. Göran Arvidson joined Procordia in 1988 as Group Controller and has been actively involved in all major transactions within Procordia/Pharmacia, the acquisition of Pharmacia in 1989, Carlo Erba in 1993, the merger of Pharmacia and Upjohn in 1995, and the acquisition of Monsanto in 1999. Göran has held various controller positions within Procordia and Pharmacia.
		Erik Kinnman – Vice President, Chief Strategic Officer and Head of Investor Relations & Public Affairs Born 1958. Associate Professor at the Karolinska Institute. Board certified physician in Neurology and Pain Management from the Karolinska Hospital. Holds an eMBA from the Stockholm School of Economics. Erik Kinnman joined Biovitrum from a position as Project Director Global R&D Strategy at AstraZeneca. Erik has previously held a number of senior leadership positions within AstraZeneca, Sanofi-Synthelabo Scandinavia and Parke-Davies/Warner-Lambert Norden AB. Erik also has experience from the financial sector where he has acted as Head of a health care sector analysis team at Danske Securities AB and before that as a health care Fund Manager at Aragon Fondkommission AB.
		Lena Nyström - Vice President and Head of Operations Born 1956. Has a Master of Science in Chemical Engineering from KTH in Stockholm. Lena joined Kabi Vitrum in 1984 in the process development organization. Since 1995 Lena has been in various management positions within the process development and manufacturing units.
		Peder Walberg –  Vice President and Head of Business Development & Strategy Born in 1974, MD and BSc in Economics and Business Administration from Uppsala University, Sweden. Peder joined Swedish Orphan International in 2007 from Novartis, where he was responsible for Business Development & Licensing and new product launches in the Nordic countries. Prior to Novartis, Peder served as a management and strategy consultant at the Boston Consulting Group, focusing on the Healthcare and Pharmaceutical sectors in a wide variety of projects. Peder has also gained experience from practicing as a physician in primarily surgical specialties.
		Peter Edman -  Vice President, Chief Scientific Officer and Head of Research & Development Born 1954. Ph.D. and Associate Professor in biochemistry from University of Uppsala. Peter Edman joins Biovitrum as Chief Scientific Officer from his current position as Vice President and Global Project Director, Global Development, at AstraZeneca. Peter Edman has previously held a number of senior research leadership positions within Pharmacia, Astra and AstraZeneca. He has also held a position as Director and Associate Professor at the Swedish Medical Product Agency. In addition, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, University of Uppsala.
		Maria Berggren - Vice President and Head of Human Resources Born 1961. Behavioural science. Maria joined Biovitrum from Capgemini Sverige AB, where she was employed as People Relationship Manager for Technology Services. As a member of the management team, Maria was responsible for human-resources issues for the organization’s 850 employees. Maria began her career in 1986 at Ericsson, where she held various senior human-resources positions over a period of ten years, including at Ericsson Data AB, Ericsson Business Networks AB and the Enterprise Networks division. Before being employed by Capgemini Sverige AB in 2001, Maria had her own business and worked as a consultant in human resources and management development.
		Fredrik Berg –  Vice President, General Counsel and Head of Legal & Intellectual Property Born 1955. Master of Law. After having started his legal career at the law firm Tisell & Co., Fredrik Berg joined KabiVitrum in 1988. He has since held various positions as company lawyer and head of legal services at Procordia, Kabi Pharmacia and Pharmacia & Upjohn. In 1996, he joined the law firm Lindahl, but was recruited back to Pharmacia & Upjohn in 1997. Prior to joining Biovitrum, Fredrik was Head of Legal/Intellectual Property at Pharmacia AB and General Counsel for Pharmacia Europe, Middle East, and Africa.
		Kennet Rooth – Vice President and Head of Sales & Marketing Born 1955.  Chemistry and Biology at Stockholm University and General Management at INSEAD-CEDEP. Kennet joined Swedish Orphan International in 2005 as Country Manager for Sweden. In 2006 he became Director International Marketing & Sales with responsibility for the international expansion and the establishment of subsidiaries in several European countries. From 1989 to 2005 Kennet was working at Bristol-Myers Squibb, where he held various positions both in Sweden and internationally, such as Executive Director, Country Manager, Business Unit Manager and Product Manager. Kennet began his career in 1985 as a Product Specialist at Ciba-Geigy.

Guidelines remuneration 2009